Roche’s skin cancer drug Erivedge pulled from CDF
admin 13th October 2017 Uncategorised 0Roche’s Erivedge could be removed from the Cancer Drugs Fund within months after the National Institute for Health and Care Excellence ruled that the drug was not a cost-effective treatment for skin cancer.
More: Roche’s skin cancer drug Erivedge pulled from CDF
Source: News